# Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome

Study · id `cardio:ct-nct01660373` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01660373](<https://clinicaltrials.gov/study/NCT01660373>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01660373

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01660373. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01660373, source copy `cardio:ctgov-nct01660373-2012-12-18`, retrieved 2026-10-31)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01660373, source copy `cardio:ctgov-nct01660373-2012-12-18`, retrieved 2026-10-31)
- Primary completion: 2013-08 (anticipated) (ClinicalTrials.gov record NCT01660373, source copy `cardio:ctgov-nct01660373-2012-12-18`, retrieved 2026-10-31)
- Completion: 2013-08 (anticipated) (ClinicalTrials.gov record NCT01660373, source copy `cardio:ctgov-nct01660373-2012-12-18`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT01660373, source copy `cardio:ctgov-nct01660373-2012-12-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01660373-2012-12-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
- Acronym: TE-CLOT
- Condition: Non-ST Segment Elevation Acute Coronary Syndrome
- Intervention (Drug): Tirofiban
- Intervention (Drug): Ticagrelor
- Lead sponsor: Pusan National University Yangsan Hospital
- Lead sponsor class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry lists this organization as the lead sponsor: Pusan National University Yangsan Hospital (`cardio:org-pusan-national-university-yangsan-hospital`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial (`cardio:pubmed-26581884`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0d971a0e81010980c8c3ec984fb68ac236e47ad5849d102164be2135dcca09b6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
